Anthracycline improves the outcome of neoadjuvant trastuzumab-treated breast cancer patients with Fc gamma RIIIA F/F genotype by decreasing the ratios of CD8+PD1+and CD68+PDL1+cells
CANCER RESEARCH（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要